← All trials
NCT05067894
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2021
- Primary completion
- Feb 28, 2022
- Completion date
- Mar 31, 2022
- First posted
- Oct 5, 2021
- Last posted
- Nov 9, 2021
- Enrollment
- 780
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- PT Bio FarmaLead sponsor
- University of IndonesiaOverall official - principal investigator
- University of IndonesiaCollaborator
- Government of IndonesiaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.